Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10

Abstract Bringing together topic-related European Union (EU)-funded projects, the so-called “NanoSafety Cluster” aims at identifying key areas for further research on risk assessment procedures for nanomaterials (NM). The outcome of NanoSafety Cluster Working Group 10, this commentary presents a vision for concern-driven integrated approaches for the (eco-)toxicological testing and assessment (IATA) of NM. Such approaches should start out by determining concerns, i.e., specific information needs for a given NM based on realistic exposure scenarios. Recognised concerns can be addressed in a set of tiers using standardised protocols for NM preparation and testing. Tier 1 includes determining physico-chemical properties, non-testing (e.g., structure–activity relationships) and evaluating existing data. In tier 2, a limited set of in vitro and in vivo tests are performed that can either indicate that the risk of the specific concern is sufficiently known or indicate the need for further testing, including details for such testing. Ecotoxicological testing begins with representative test organisms followed by complex test systems. After each tier, it is evaluated whether the information gained permits assessing the safety of the NM so that further testing can be waived. By effectively exploiting all available information, IATA allow accelerating the risk assessment process and reducing testing costs and animal use (in line with the 3Rs principle implemented in EU Directive 2010/63/EU). Combining material properties, exposure, biokinetics and hazard data, information gained with IATA can be used to recognise groups of NM based upon similar modes of action. Grouping of substances in return should form integral part of the IATA themselves.

[1]  H. Bouwmeester,et al.  Presence and risks of nanosilica in food products , 2011, Nanotoxicology.

[2]  Susan Wijnhoven,et al.  Approaches to the safety assessment of engineered nanomaterials (ENM) in food. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  Markus Schulz,et al.  Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. , 2009, Mutation research.

[4]  Christian Micheletti,et al.  Weight of Evidence approach for the relative hazard ranking of nanomaterials , 2011, Nanotoxicology.

[5]  Christian Micheletti,et al.  Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies. , 2011, Environment international.

[6]  G. Storm,et al.  Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model. , 2012, ALTEX.

[7]  Albert Duschl,et al.  Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects , 2011, Particle and Fibre Toxicology.

[8]  Antonio Marcomini,et al.  Application of a quantitative weight of evidence approach for ranking and prioritising occupational exposure scenarios for titanium dioxide and carbon nanomaterials , 2014, Nanotoxicology.

[9]  Albert A Koelmans,et al.  Analysis of engineered nanomaterials in complex matrices (environment and biota): General considerations and conceptual case studies , 2012, Environmental toxicology and chemistry.

[10]  F. Coppedè,et al.  Genotoxicity induced by arsenic compounds in peripheral human lymphocytes analysed by cytokinesis-block micronucleus assay. , 2007, Mutagenesis.

[11]  K. Schirmer,et al.  Comparative evaluation of particle properties, formation of reactive oxygen species and genotoxic potential of tungsten carbide based nanoparticles in vitro. , 2012, Journal of hazardous materials.

[12]  M. Tapia,et al.  Approaches For Safety Assessment , 2002 .

[13]  Jiri Aubrecht,et al.  New and emerging technologies for genetic toxicity testing , 2011, Environmental and molecular mutagenesis.

[14]  Vicki Stone,et al.  Relating the physicochemical characteristics and dispersion of multiwalled carbon nanotubes in different suspension media to their oxidative reactivity in vitro and inflammation in vivo , 2010, Nanotoxicology.

[15]  Theo Vermeire,et al.  Risk assessment of chemicals : an introduction , 2007 .

[16]  David Brown,et al.  Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[17]  Sydney Brenner,et al.  The End of the Beginning , 2000, Science.

[18]  Alexandra Kroll,et al.  Testing Metal‐Oxide Nanomaterials for Human Safety , 2010, Advanced materials.

[19]  Andrew P. Worth,et al.  Intelligent Testing Strategies , 2007 .

[20]  Agnes G. Oomen,et al.  Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. , 2012, ACS nano.

[21]  Gian Paolo Rossini,et al.  Towards tailored assays for cell-based approaches to toxicity testing. , 2012, ALTEX.

[22]  Bernadene A Magnuson,et al.  A Method to Assess the Quality of Studies That Examine the Toxicity of Engineered Nanomaterials , 2010, International journal of toxicology.

[23]  J. Schnekenburger,et al.  Not ready to use – overcoming pitfalls when dispersing nanoparticles in physiological media , 2008 .

[24]  Jamie R Lead,et al.  Nanomaterials in the environment: Behavior, fate, bioavailability, and effects , 2008, Environmental toxicology and chemistry.

[25]  R. Pasricha HRTEM characterization in environmental risk assessment of engineered nanoparticles. , 2011, Journal of biomedical nanotechnology.

[26]  Lucia Migliore,et al.  Epigenetic effects of nano-sized materials. , 2013, Toxicology.

[27]  A. Boxall,et al.  Detection and characterization of engineered nanoparticles in food and the environment , 2008, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[28]  Peter Wick,et al.  Toward the development of decision supporting tools that can be used for safe production and use of nanomaterials. , 2013, Accounts of chemical research.

[29]  D. Blacker Food for thought. , 2013, JAMA neurology.

[30]  Maria Dusinska,et al.  Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.

[31]  Albert A Koelmans,et al.  Ecotoxicity test methods for engineered nanomaterials: Practical experiences and recommendations from the bench , 2012, Environmental toxicology and chemistry.

[32]  Xiang Wang,et al.  Nanomaterial toxicity testing in the 21st century: use of a predictive toxicological approach and high-throughput screening. , 2013, Accounts of chemical research.

[33]  S. Mintova,et al.  Reactive oxygen species mediated DNA damage in human lung alveolar epithelial (A549) cells from exposure to non-cytotoxic MFI-type zeolite nanoparticles. , 2012, Toxicology letters.

[34]  Jeffrey B. Cheng,et al.  Genetics and epigenetics of the skin meet deep sequence. , 2012, The Journal of investigative dermatology.

[35]  Dik van de Meent,et al.  Considerations on the EU definition of a nanomaterial: science to support policy making. , 2013, Regulatory toxicology and pharmacology : RTP.

[36]  Robert Landsiedel,et al.  Hazard identification of inhaled nanomaterials: making use of short-term inhalation studies , 2012, Archives of Toxicology.

[37]  Ted Richer,et al.  Anon , 2008, Daedalus.

[38]  I. Koturbash,et al.  Alterations in histone H4 lysine 20 methylation: implications for cancer detection and prevention. , 2012, Antioxidants & redox signaling.

[39]  James F. Ranville,et al.  Nanoparticle analysis and characterization methodologies in environmental risk assessment of engineered nanoparticles , 2008, Ecotoxicology.

[40]  M. Fenech Cytokinesis-block micronucleus cytome assay , 2007, Nature Protocols.

[41]  Marco Vighi,et al.  SCCP (Scientific Committee on Consumer Products) / SCHER (Scientific Committee on Health& Environment Risks) / SCENIHR (Scientific Committee on Emerging and Newly- Identified Health Risks) opinion on: Risk assessment methodologies and approaches for genotoxic and carcinogenic substances , 2009 .

[42]  W. D. de Jong,et al.  The kinetics of the tissue distribution of silver nanoparticles of different sizes. , 2010, Biomaterials.

[43]  Teresa F. Fernandes,et al.  Practical considerations for conducting ecotoxicity test methods with manufactured nanomaterials: what have we learnt so far? , 2012, Ecotoxicology.

[44]  Thomas Hartung,et al.  t⁴ workshop report. Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials. , 2011, ALTEX.

[45]  S. Merhar,et al.  Letter to the editor , 2005, IEEE Communications Magazine.

[46]  Marike Kolossa-Gehring,et al.  The carcinogenic potential of nanomaterials, their release from products and options for regulating them. , 2011, International journal of hygiene and environmental health.

[47]  M. Marinovich,et al.  Risk Assessment of Products of Nanotechnologies , 2009 .

[48]  R. Cho,et al.  Genetics and Epigenetics of the Skin Meet Deep , 2012 .

[49]  Robert Kavlock,et al.  The U.S. Environmental Protection Agency Strategic Plan for Evaluating the Toxicity of Chemicals , 2010, Journal of toxicology and environmental health. Part B, Critical reviews.

[50]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[51]  G. Oberdörster,et al.  Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology , 2010, Journal of internal medicine.

[52]  T. Hartung Toxicology for the twenty-first century , 2009, Nature.

[53]  Green Paper Communication from the Commission , 1999 .

[54]  Luca Costantino,et al.  Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. , 2012, Nanomedicine.

[55]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[56]  Daniel L Villeneuve,et al.  Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment , 2010, Environmental toxicology and chemistry.

[57]  K. Fong,et al.  Genomics and the respiratory effects of air pollution exposure , 2012, Respirology.

[58]  B. Burlinson,et al.  The in vitro and in vivo comet assays. , 2012, Methods in molecular biology.

[59]  M. Szyf The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[60]  Frank Caruso,et al.  Emerging techniques in proteomics for probing nano-bio interactions. , 2012, ACS nano.

[61]  Lang Tran,et al.  Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges , 2013, Critical reviews in toxicology.

[62]  Robert Landsiedel,et al.  Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.

[63]  Robert Landsiedel,et al.  Development of a short-term inhalation test in the rat using nano-titanium dioxide as a model substance. , 2009, Inhalation toxicology.

[64]  H. Bouwmeester,et al.  Knowledge gaps in risk assessment of nanosilica in food: evaluation of the dissolution and toxicity of different forms of silica , 2013, Nanotoxicology.

[65]  Peter Wick,et al.  The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry , 2010, Journal of nanobiotechnology.

[66]  T. Hofmann,et al.  Influence of surface functionalization and particle size on the aggregation kinetics of engineered nanoparticles. , 2012, Chemosphere.

[67]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[68]  Peter Wick,et al.  Nanotoxicology: an interdisciplinary challenge. , 2011, Angewandte Chemie.

[69]  Jason M Unrine,et al.  Ceria-engineered nanomaterial distribution in, and clearance from, blood: size matters. , 2012, Nanomedicine.